Add Tribune As Your Trusted Source
TrendingVideosIndia
Opinions | CommentEditorialsThe MiddleLetters to the EditorReflections
UPSC | Exam ScheduleExam Mentor
State | Himachal PradeshPunjabJammu & KashmirHaryanaChhattisgarhMadhya PradeshRajasthanUttarakhandUttar Pradesh
City | ChandigarhAmritsarJalandharLudhianaDelhiPatialaBathindaShaharnama
World | ChinaUnited StatesPakistan
Diaspora
Features | The Tribune ScienceTime CapsuleSpectrumIn-DepthTravelFood
Business | My MoneyAutoZone
News Columns | Straight DriveCanada CallingLondon LetterKashmir AngleJammu JournalInside the CapitalHimachal CallingHill ViewBenchmark
Don't Miss
Advertisement

Enforcement Directorate attaches assets of Solan ex-deputy drug controller

Unlock Exclusive Insights with The Tribune Premium

Take your experience further with Premium access. Thought-provoking Opinions, Expert Analysis, In-depth Insights and other Member Only Benefits
Yearly Premium ₹999 ₹349/Year
Yearly Premium $49 $24.99/Year
Advertisement

New Delhi, January 14

Advertisement

The Enforcement Directorate (ED) said on Friday that it had attached assets worth Rs 2.07 crore of a former Himachal Pradesh deputy drug controller as part of a money laundering probe against him linked to charges of alleged bribery and possession of assets disproportionate to his known sources of income.

Advertisement

A provisional order had been issued under the Prevention of Money Laundering Act (PMLA) against Kapil Dhiman. Eight immovable properties in Solan, Mandi and Kullu in Himachal Pradesh and Panchkula in Haryana and bank balances, fixed deposits and insurance policies had been attached.

The properties to the tune of Rs 2.07 crore in his name and in the name of his family members and some firms were “acquired out of the proceeds of crime”, the ED said in a statement. — PTI

Used to take bribes

Advertisement

The ED probe found that Kapil Dhiman, the then deputy drug controller and licensing authority, Solan, used to take bribes for issuing and renewing licences of pharmaceutical companies.

Advertisement
Show comments
Advertisement